%0 Journal Article
%T Recent Trends in Prostate Cancer Incidence by Age, Cancer Stage, and Grade, the United States, 2001每2007
%A Jun Li
%A Joseph A. Djenaba
%A Ashwini Soman
%A Sun Hee Rim
%A Viraj A. Master
%J Prostate Cancer
%D 2012
%I Hindawi Publishing Corporation
%R 10.1155/2012/691380
%X Objective. To examine prostate cancer trends by demographic and tumor characteristics because a comprehensive examination of recent prostate cancer incidence rates is lacking. Patients and Methods. We described prostate cancer incidence rates and trends using the 2001每2007 National Program of Cancer Registries and Surveillance, Epidemiology, and End Results Program data (representing over 93% of US population). Because of coding changes in cancer grade, we restricted analysis to 2004每2007. We conducted descriptive and trend analyses using SEER*Stat. Results. The overall prostate cancer incidence rate was stable from 2001 to 2007; however, rates significantly increased among men aged 40每49 years (APC = 3.0) and decreased among men aged 70每79 years (APC = 2.3), and 80 years or older (APC = ˋ4.4). About 42% of localized prostate cancers diagnosed from 2004 to 2007 were poorly differentiated. The incidence of poorly differentiated cancer significantly increased among localized (APC = 8.0) and regional stage (APC = 6.1) prostate cancers during 2004每2007. Conclusions. The recent trend in prostate cancer incidence was stable but varied dramatically by age. Given the large proportion of poorly differentiated disease among localized prostate cancers and its increasing trend in more recent years, continued monitoring of prostate cancer incidence and trends by demographic and tumor characteristics is warranted. 1. Introduction Prostate cancer is the most commonly diagnosed non-skin cancer and the second leading cause of cancer death among American men. Each year, approximately 220,000 men are diagnosed with prostate cancer and 29,000 die from it [1]. With the introduction of the prostate-specific antigen (PSA) testing in the mid-1980s, prostate cancer incidence rate increased drastically, at about 12% per year, and peaked in 1992 [2]. The rate subsequently declined, at about 10% per year for the following three years and then appeared to stabilize from 1995 to 2005 [2, 3]. In 2011, Kohler et al. reported a stable trend of prostate cancer incidence from 1998 to 2007; however, demographic and clinical factors were not examined in this study [4]. With the widespread use of the PSA test, the mean age at diagnosis dropped substantially, from 72.2 years between 1988-1989 to 67.2 years between 2004 and 2005 [5]. Studies using Surveillance, Epidemiology, and End Results Program (SEER) data have shown that the distribution of prostate cancer stage and grade has also dramatically changed, with localized and moderately differentiated tumors becoming predominant [6, 7]. Age
%U http://www.hindawi.com/journals/pc/2012/691380/